The devicemaker’s filing revealed the compensation packages for five executives from 2021 to 2023. Compensation packages include salary, stock and option awards, nonequity incentive plan compensation, and other pay.
Here’s what each executive made during that time:
Geoffrey Martha, CEO and chair
Fiscal year 2023: $15.4 million
Fiscal year 2022: $17.9 million
Fiscal year 2021: $17.5 million
Karen Parkhill, executive vice president and CFO
Fiscal year 2023: $6.1 million
Fiscal year 2022: $7.5 million
Fiscal year 2021: $8.9 million
Sean Salmon, executive vice president and president of cardiovascular
Fiscal year 2023: $5.4 million
Rob ten Hoedt, executive vice president and president of global regions
Fiscal year 2023: $5 million
Fiscal year 2022: $5.9 million
Robert White, executive vice president and president of medical surgical
Fiscal year 2023: $5 million
Fiscal year 2022: $6.3 million
Fiscal year 2021: $7.2 million
